CTOs on the Move

Enara Health

www.enarahealth.com

 
Enara Health is building a data-driven platform and network to scale obesity treatment. Based in San Mateo, Calif., and operating since March 2015, Enara Health offers unique hybrid digital and in-person weight loss programs based on precision medicine. By combining mobile technology with health care visits and providing patients with personalized physician-driven medical weight loss programs, Enara Health routinely helps patients lose—and keep off—more than 15% of their baseline weight, which is far greater than the results seen with other m-health interventions.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.enarahealth.com
  • 3050 South Delaware Street Suite 130
    San Mateo, CA USA 94403
  • Phone: 650.319.8654

Executives

Name Title Contact Details
Felipe Baytelman
 Chief Technology Officer Profile

Similar Companies

Cempa Community Care

Our mission is to champion healthy communities by providing affordable, compassionate, and high-quality care.

VISTA HealthPlan

VISTA HealthPlan is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.

Curio Wellness

Founded in 2014 in Baltimore, Maryland, Curio Wellness is a cGMP certified, vertically integrated medical cannabis company and trusted healthcare partner. Recognized as the leading wellness brand in cannabis by BDS Analytics, Curio is committed to serving patients with targeted, effective, and reliable cannabis-based medicine.

nmc holdings

nmc holdings is a Irving, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Aratana Terapeutics

Aratana Therapeutics, Inc., a development-stage biopharmaceutical company, focuses on the licensing, development, and commercialization of prescription medicines for pets in the United States and Europe. It develops AT-001, a prostaglandin E receptor 4 antagonist to treat the pain and inflammation associated with osteoarthritis in dogs, as well as for the management of pain in cats; AT-002, a potent and selective ghrelin agonist for the stimulation of appetite in cats and dogs; and AT-003, a bupivacaine liposome injectable suspension to manage post-operative pain in cats and dogs following surgery. The company was founded in 2010 and is headquartered in Kansas City, Kansas.